AwardTape · Defense awards · Medical · Drugs and biologicals · HT009025FG081100
HT009025FG081100: $44K BPA call to Sofie Co
Sofie Co holds a BPA call from Defense Health Agency with $44K obligated since Oct 2023, against a ceiling of $44K. Latest action Jul 23, 2025.
Radiopharmaceutical needed for prostate cancer patient with metastatic lesions after definite treatment sofie (s0f-neuraceq)
| PIID | HT009025FG081100 |
|---|---|
| Type | BPA call |
| Parent award | HT001424A0002 |
| Company | Sofie Co |
| Agency | Defense Health Agency |
| Contracting office | GPC COMPONENT PROGRAM MANAGER |
| Category | Medical · Drugs and biologicals |
| PSC | 6506 BLOOD AND BLOOD PRODUCTS |
| NAICS | 325412 PHARMACEUTICAL PREPARATION MANUFACTURING |
| Obligated since Oct 2023 | $44K |
| Total obligated (lifetime) | $44K |
| Ceiling (base and all options) | $44K |
| Base date | Jul 23, 2025 |
| Latest action | Jul 23, 2025 |
| End date | Sep 30, 2025 |
| Actions since Oct 2023 | 1 |
| Pricing | Firm fixed price |
| Competition | Competed under simplified acquisition |
| Place of performance | VA |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial